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SUMMARY. The plasma pharmacokinetics, tissue distribution, excretion, and metabolism of gambogenic
acid (GNA), potential antitumor candidate, were investigated in rats. GNA showed linear pharmacokinet-
ic characteristics in rats within the test dose (1, 2, and 4 mg/kg). The t1/2β was 40.38-41.16 min. GNA
showed an extensive distribution into multiple tissues, and the bile excretion is the major pathway of ex-
cretion, accounting for 52.12 %. About 40 % of GNA might undergo metabolism in vivo and the main
phase I metabolites of GNA may be 10-hydroxygambogenic acid and 9,10-epoxygambogenic acid.
